Moolec Science SA
MLEC0.419USD
-0.024-5.42%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
1.67MMarket Cap
LossP/E TTM
More Details of Moolec Science SA Company
Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.
Moolec Science SA Info
Ticker SymbolMLEC
Company nameMoolec Science SA
IPO dateJan 03, 2023
CEOMr. Robert M. Bennett
Number of employees52
Security typeOrdinary Share
Fiscal year-endJan 03
Address17, Boulevard F.W. Raiffeisan
CityLUXEMBOURG
Stock exchangeNASDAQ Capital Market Consolidated
CountryLuxembourg
Postal code2411
Phone35226496565
Websitehttps://www.moolecscience.com/
Ticker SymbolMLEC
IPO dateJan 03, 2023
CEOMr. Robert M. Bennett
Company Executives of Moolec Science SA
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew D. Hamer
Mr. Andrew D. Hamer
Independent Director
Independent Director
--
--
Mr. James W. Keyes
Mr. James W. Keyes
Independent Director
Independent Director
--
--
Mr. Jeffrey A. (Jeff) Rich
Mr. Jeffrey A. (Jeff) Rich
Independent Director
Independent Director
--
--
Mr. Robert M. Bennett
Mr. Robert M. Bennett
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Eric Ver Ploeg
Dr. Eric Ver Ploeg
President
President
--
--
Mr. William W. Bunker
Mr. William W. Bunker
Vice Chairman of the Board, Chief Financial Officer
Vice Chairman of the Board, Chief Financial Officer
--
--
Mr. Patrick Brandt
Mr. Patrick Brandt
Vice President - Acquisitions, Corporate Development
Vice President - Acquisitions, Corporate Development
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew D. Hamer
Mr. Andrew D. Hamer
Independent Director
Independent Director
--
--
Mr. James W. Keyes
Mr. James W. Keyes
Independent Director
Independent Director
--
--
Mr. Jeffrey A. (Jeff) Rich
Mr. Jeffrey A. (Jeff) Rich
Independent Director
Independent Director
--
--
Mr. Robert M. Bennett
Mr. Robert M. Bennett
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Eric Ver Ploeg
Dr. Eric Ver Ploeg
President
President
--
--
Mr. William W. Bunker
Mr. William W. Bunker
Vice Chairman of the Board, Chief Financial Officer
Vice Chairman of the Board, Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Union Group Ventures Limited.
13.93%
Theo I SCSp
10.88%
Biotech Company LLC
2.68%
Bioceres Group PLC
0.55%
Citadel Advisors LLC
0.33%
Other
71.63%
Shareholders
Shareholders
Proportion
Union Group Ventures Limited.
13.93%
Theo I SCSp
10.88%
Biotech Company LLC
2.68%
Bioceres Group PLC
0.55%
Citadel Advisors LLC
0.33%
Other
71.63%
Shareholder Types
Shareholders
Proportion
Corporation
28.04%
Individual Investor
0.76%
Hedge Fund
0.33%
Investment Advisor
0.32%
Other
70.55%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
14
109.00
0.00%
-22.78K
2025Q2
28
3.15M
27.23%
-1.53M
2025Q1
30
3.15M
27.25%
-1.53M
2024Q4
39
31.43M
81.74%
-17.08M
2024Q3
44
31.41M
81.67%
-17.61M
2024Q2
82
31.49M
81.90%
-25.98M
2024Q1
87
32.51M
86.40%
-12.56M
2023Q4
89
34.47M
91.94%
-12.80M
2023Q3
92
34.47M
91.94%
-13.00M
2023Q2
95
34.69M
93.17%
-13.08M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Union Group Ventures Limited.
1.52M
13.93%
--
--
Feb 06, 2025
Theo I SCSp
1.19M
10.88%
--
--
Jun 30, 2024
Biotech Company LLC
291.40K
2.68%
--
--
Jun 30, 2024
Bioceres Group PLC
60.08K
0.55%
--
--
Jun 30, 2024
Citadel Advisors LLC
--
0%
-7.09K
-100.00%
Jun 30, 2025
Bransfield (Kyle P)
35.00K
0.32%
-68.50K
-66.18%
Jun 30, 2024
Lopez Lecube (Jose)
30.64K
0.28%
--
--
Jun 30, 2024
Salinas (Martin)
6.00K
0.06%
--
--
Jun 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Moolec Science SA?
The top five shareholders of Moolec Science SA are:
Union Group Ventures Limited. holds 1.52M shares, accounting for 13.93% of the total shares.
Theo I SCSp holds 1.19M shares, accounting for 10.88% of the total shares.
Biotech Company LLC holds 291.40K shares, accounting for 2.68% of the total shares.
Bioceres Group PLC holds 60.08K shares, accounting for 0.55% of the total shares.
Citadel Advisors LLC holds 0.00 shares, accounting for 0.00% of the total shares.
Union Group Ventures Limited. holds 1.52M shares, accounting for 13.93% of the total shares.
Theo I SCSp holds 1.19M shares, accounting for 10.88% of the total shares.
Biotech Company LLC holds 291.40K shares, accounting for 2.68% of the total shares.
Bioceres Group PLC holds 60.08K shares, accounting for 0.55% of the total shares.
Citadel Advisors LLC holds 0.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Moolec Science SA?
The top three shareholder types of Moolec Science SA are:
Union Group Ventures Limited.
Theo I SCSp
Biotech Company LLC
Union Group Ventures Limited.
Theo I SCSp
Biotech Company LLC
How many institutions hold shares of Moolec Science SA (MLEC)?
As of 2025Q3, 14 institutions hold shares of Moolec Science SA, with a combined market value of approximately 109.00, accounting for 0.00% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -27.23%.
What is the biggest source of revenue for Moolec Science SA?
In --, the -- business generated the highest revenue for Moolec Science SA, amounting to -- and accounting for --% of total revenue.
